Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis

• Main Authors: Mafalda Bacalhau (Author), Mariana Camargo (Author), Grace A. V. Magalhães-Ghiotto (Author), Sybelle Drumond (Author), Carlos Henrique M. Castelletti (Author), Miquéias Lopes-Pacheco (Author)
• Formato: Libro
• Publicado: MDPI AG, 2023-03-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Cystic fibrosis (CF) is a potentially fatal monogenic disease that causes a progressive multisystemic pathology. Over the last decade, the introduction of CF transmembrane conductance regulator (CFTR) modulator drugs into clinical practice has profoundly modified the lives of many people with CF (Pw...